Comparison of Left Ventricular Ejection Fraction and Exercise Capacity as Predictors of Two- and Five-Year Mortality Following Acute Myocardial Infarction

American Journal of Cardiology

Volumn 99, Issue 4, 2007, Pages 436-441

  Dutcher, Jacob R ^a   Kahn, Joel ^a   Grines, Cindy ^a   Franklin, Barry ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ADULT; ANGIOPLASTY; ARTICLE; BICYCLE ERGOMETER; COHORT ANALYSIS; EVALUATION; EXERCISE; EXERCISE TEST; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; INDEPENDENT VARIABLE; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; RADIOISOTOPE VENTRICULOGRAPHY; REST; ST SEGMENT ELEVATION; STATISTICAL SIGNIFICANCE;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ANGIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PHYSICAL ENDURANCE; PREDICTIVE VALUE OF TESTS; RADIONUCLIDE VENTRICULOGRAPHY; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33846805350     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2006.08.053     Document Type: Article

References (25)

1. Sanz G., Castaner A., Betriu A., Magrina J., Roig E., Coll S., Pare J.C., and Navarro-Lopez F. Determinants of prognosis in survivors of acute myocardial infarction: a prospective clinical angiographic study. N Engl J Med 306 (1982) 1065-1070
2. The Multicenter Post-infarction Research Group. Risk stratification and survival after myocardial infarction. N Engl J Med 309 (1983) 331-336
3. Kambara H., Nakagawa M., Kinoshita M., and Kawai C. Long-term prognosis after myocardial infarction: univariate and multivariate analysis of clinical characteristics in 1000 patients. Clin Cardiol 16 (1993) 872-878
4. TIMI Study Group. Value of radionuclide rest and exercise left ventricular ejection fraction in assessing survival of patients after thrombolytic therapy for acute myocardial infarction: results of Thrombolysis In Myocardial Infarction (TIMI) phase II study. J Am Coll Cardiol 26 (1995) 73-79
5. MADIT II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346 (2002) 877-883
6. Waldecker B., Wass W., Haberbosch W., Voss R., Heizmann H., and Tillmanns H. Long-term follow-up after direct percutaneous transluminal coronary angioplasty for acute myocardial infarction. J Am Coll Cardiol 32 (1998) 1320-1325
7. Pilote L., Silberberg J., Lisbona R., and Sniderman A. Prognosis in patients with low left ventricular ejection fraction after myocardial infarction: importance of exercise capacity. Circulation 80 (1989) 1636-1641
8. Vanhees L., Fagard R., Thijs L., and Amery A. Prognostic value for training-induced change in peak exercise capacity in patients with myocardial infarcts and patients with coronary bypass surgery. Am J Cardiol 76 (1995) 1014-1019
9. Volpi A., De Vita C., Franzosi M.G., Geraci E., Maggioni A.P., Mauri F., Negri E., Santoro E., Tavazzi L., and Tognoni G. Determinants of 6-month mortality in survivors of myocardial infarction after thrombolysis. Results of the GISSI-2 data base. The Ad hoc Working Group of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-2 Data Base. Circulation 8 (1993) 416-429
10. Bigi R., Cortigiani L., Gregori D., De Chiara B., and Fiorentini C. Exercise versus recovery electrocardiography in predicting mortality in patients with uncomplicated myocardial infarction. Eur Heart J 25 (2004) 558-564
11. Valeur N., Clemmensen P., Saunamaki K., and Grande P. The prognostic value of pre-discharge exercise testing after myocardial infarction treated with either primary PCI or fibrinolysis: a DANAMI-2 substudy. Eur Heart J 26 (2005) 119-127
12. PAMI-II Trial Investigators. A prospective, randomized evaluation of prophylactic intraaortic balloon counterpulsation in high risk patients with acute myocardial infarction treated with primary angioplasty. J Am Coll Cardiol 29 (1997) 1459-1467
13. American College of Sports Medicine. In: Franklin B.A. (Ed). ACSM's Guidelines for Exercise Testing and Prescription. 6th Ed. (2000), Lippincott Williams & Wilkins, Baltimore, MD 300-312
14. Kavanagh T., Mertens D.J., Hamm L.F., Beyene J., Kennedy J., Corey P., and Shephard R.J. Prediction of long term prognosis in 12,169 men referred for cardiac rehabilitation. Circulation 106 (2002) 666-671
15. Kavanagh T., Mertens D.J., Hamm L.F., Beyene J., Kennedy J., Corey P., and Shephard R.J. Peak oxygen intake and cardiac mortality in women referred for cardiac rehabilitation. J Am Coll Cardiol 42 (2003) 2139-2143
16. DINAMIT Investigators. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med 351 (2004) 2481-2488
17. The INSPIRE Investigators. Suppression of post-infarction myocardial ischemia with medical and revascularisation therapies: results from the adenosine sestamibi post-infarction evaluation (INSPIRE) trial. J Nucl Cardiol 11 (2004) 458-469
18. Blair S.N., Kohl III H.W., and Barlow C.E. Changes in physical fitness and all-cause mortality. A prospective study of healthy and unhealthy men. JAMA 273 (1995) 1093-1098
19. Gulati M., Pandey D.K., Arnsdorf M.F., Lauderdale D.S., Thisted R.A., Wicklund R.H., Al-Hani A.J., and Black H.R. Exercise capacity and the risk of death in women: the St James Women Take Heart Project. Circulation 108 (2003) 1554-1559
20. Myers J., Prakash M., Froelicher V., Do D., Partington S., and Atwood J.E. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med 346 (2002) 793-801
21. Dorn J., Naughton J., Imamura D., and Trevisan M. Results of a multicenter randomized clinical trial of exercise and long-term survival in myocardial infarction patients: the National Exercise and heart Disease Project (NEHDP). Circulation 100 (1999) 1764-1769
22. CLARITY-TIMI 28 Investigators. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med 352 (2005) 1179-1189
23. The CADILLAC Investigators. Impact of stenting and abciximab in patients with diabetes mellitus undergoing primary angioplasty in acute myocardial infarction (the CADILLAC Trial). Am J Cardiol 95 (2005) 1-7
24. The CADILLAC Investigators. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Engl J Med 346 (2002) 957-966
25. Neumann F.J., Kastrati A., Schmitt C., Blasini R., Hadamitzky M., Mehilli J., Gawaz M., Schleef M., Seyfarth M., Dirschinger J., and Schomig A. Effect of glycoprotein IIb/IIIa receptor blockade with abciximab on clinical and angiographic restenosis rate after the placement of coronary stents following acute myocardial infarction. J Am Coll Cardiol 35 (2000) 915-921